Inactive Instrument

News ITUS Corp Nasdaq

Equities

US45069V2034

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines	May. 08	PR
Anixa Biosciences, Inc. Enters into a Joint Development Agreement with Cleveland Clinic to Develop Novel Vaccines for Various Cancer Types	May. 08	CI
Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja	May. 06	PR
Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 and 9, 2024	May. 01	AQ
Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024	Apr. 30	PR
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board	Apr. 19	AQ
Anixa Biosciences Welcomes Sanjay Juneja to Its Cancer Business Advisory Board	Apr. 18	CI
InvestorBrandMedia: Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth	Mar. 20	AQ
Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties	Mar. 14	PR
Anixa Biosciences, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	Mar. 12	CI
Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress	Mar. 11	PR
Anixa Biosciences Initiates Higher Dosing in Phase 1 Study of Ovarian Cancer Treatment	Feb. 12	MT
Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial	Feb. 12	PR
Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference	Jan. 29	PR
Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology	Jan. 24	AQ
Anixa Biosciences Says Japan Grants Patent to Ovarian Cancer Vaccine Technology	Jan. 23	MT
Anixa Biosciences, Inc. Announces Japanese Patent on Ovarian Cancer Vaccine Technology	Jan. 23	CI
North American Morning Briefing : Stock Futures Steady as Earnings Season Ramps Up	Jan. 23	DJ
Anixa Biosciences, Inc. Reports Earnings Results for the Full Year Ended October 31, 2023	Jan. 16	CI
North American Morning Briefing : Stock Futures -2-	Jan. 16	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News ITUS Corp Nasdaq

Equities

US45069V2034

Summary

Filters